COMP <GO>
CI vs NTRA // 10Y YIELD & FRED MACRO BETA
The Cigna Group (NYSE) VS. Natera Inc. (NASDAQ) • 15-METRIC TALLY: CI 7
— NTRA 5
▲ 10Y YIELD & FRED MACRO BETA LEADER: CI
LAST: $298.23 (-0.06%) • MKT CAP: $78.85B
macro-sensitivity
1.12
LAST: $414.30 (-4.98%) • MKT CAP: $62.85B
macro-sensitivity
1.09
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CI VS. NTRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CI | NTRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | -4.90% | +13.70 | CI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.51% | 0.17% | -3.68 | NTRA | /fcf-yield <GO> |
| Operating Margin | 3.30% | -13.40% | +16.70 | CI | /operating-margins <GO> |
| Net Profit Margin | 2.20% | -9.00% | +11.20 | CI | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 35.90% | -24.70 | NTRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.04% | 0.00% | +2.04 | CI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.70 | 26.00 | -23.30 | NTRA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | NTRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 64.0 | -8.20 | NTRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.12 | 1.09 | +0.03 | CI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.3x | 18.0x | -5.70 | CI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $78.85B | $62.85B | $16.01B | CI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CI REV | NTRA REV | CI GROSS % | NTRA GROSS % | CI FCF | NTRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $274.90B | $2.31B | 21.8% | — | -$2.77B | $109.1M |
| FY 2024 | $247.12B | $1.70B | 26.1% | — | -$757.4M | $69.2M |
| FY 2023 | $195.26B | $1.08B | — | — | $3.03B | -$295.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CI // BETA 1.12
NTRA // BETA 1.09